Format
Items per page
Sort by

Send to:

Choose Destination

Search results

Items: 1 to 20 of 125

1.

A Quantified Scoring System for Postoperative Complication Severity Compared to the Clavien-Dindo Classification. The Comprehensive Complication Index.

Slaman AE, Lagarde SM, Gisbertz SS, van Berge Henegouwen MI.

Dig Surg. 2015 Aug 7;32(5):361-366. [Epub ahead of print]

PMID:
26279268
2.

Neoadjuvant chemoradiotherapy plus surgery versus surgery alone for oesophageal or junctional cancer (CROSS): long-term results of a randomised controlled trial.

Shapiro J, van Lanschot JJ, Hulshof MC, van Hagen P, van Berge Henegouwen MI, Wijnhoven BP, van Laarhoven HW, Nieuwenhuijzen GA, Hospers GA, Bonenkamp JJ, Cuesta MA, Blaisse RJ, Busch OR, Ten Kate FJ, Creemers GM, Punt CJ, Plukker JT, Verheul HM, Bilgen EJ, van Dekken H, van der Sangen MJ, Rozema T, Biermann K, Beukema JC, Piet AH, van Rij CM, Reinders JG, Tilanus HW, Steyerberg EW, van der Gaast A; CROSS study group.

Lancet Oncol. 2015 Aug 5. pii: S1470-2045(15)00040-6. doi: 10.1016/S1470-2045(15)00040-6. [Epub ahead of print]

PMID:
26254683
3.

The effect of on-demand vs deep neuromuscular relaxation on rating of surgical and anaesthesiologic conditions in patients undergoing thoracolaparoscopic esophagectomy (DEPTH trial): study protocol for a randomized controlled trial.

Veelo DP, Gisbertz SS, Hannivoort RA, van Dieren S, Geerts BF, van Berge Henegouwen MI, Hollmann MW.

Trials. 2015 Aug 5;16(1):331. doi: 10.1186/s13063-015-0849-0.

4.

Laparoscopic versus open gastrectomy for gastric cancer, a multicenter prospectively randomized controlled trial (LOGICA-trial).

Haverkamp L, Brenkman HJ, Seesing MF, Gisbertz SS, van Berge Henegouwen MI, Luyer MD, Nieuwenhuijzen GA, Wijnhoven BP, van Lanschot JJ, de Steur WO, Hartgrink HH, Stoot JH, Hulsewé KW, Spillenaar Bilgen EJ, Rütter JE, Kouwenhoven EA, van Det MJ, van der Peet DL, Daams F, Draaisma WA, Broeders IA, van Stel HF, Lacle MM, Ruurda JP, van Hillegersberg R; LOGICA study group.

BMC Cancer. 2015 Jul 29;15(1):556. doi: 10.1186/s12885-015-1551-z.

5.

Electrical stimulation therapy of the lower oesophageal sphincter for refractory gastro-oesophageal reflux disease - interim results of an international multicentre trial.

Kappelle WF, Bredenoord AJ, Conchillo JM, Ruurda JP, Bouvy ND, van Berge Henegouwen MI, Chiu PW, Booth M, Hani A, Reddy DN, Bogte A, Smout AJ, Wu JC, Escalona A, Valdovinos MA, Torres-Villalobos G, Siersema PD.

Aliment Pharmacol Ther. 2015 Sep;42(5):614-25. doi: 10.1111/apt.13306. Epub 2015 Jul 8.

PMID:
26153531
6.

Accuracy of Detecting Residual Disease After Cross Neoadjuvant Chemoradiotherapy for Esophageal Cancer (preSANO Trial): Rationale and Protocol.

Noordman BJ, Shapiro J, Spaander MC, Krishnadath KK, van Laarhoven HW, van Berge Henegouwen MI, Nieuwenhuijzen GA, van Hillegersberg R, Sosef MN, Steyerberg EW, Wijnhoven BP, van Lanschot JJ; SANO study group.

JMIR Res Protoc. 2015 Jun 29;4(2):e79. doi: 10.2196/resprot.4320.

7.

Single nucleotide polymorphisms in CRTC1 and BARX1 are associated with esophageal adenocarcinoma.

van Nistelrooij AM, van der Korput HA, Broer L, van Marion R, van Berge Henegouwen MI, van Noesel CJ, Biermann K, Spaander MC, Tilanus HW, van Lanschot JJ, Hofman A, Uitterlinden AG, Wijnhoven BP, Dinjens WN.

J Carcinog. 2015 May 21;14:5. doi: 10.4103/1477-3163.157441. eCollection 2015.

8.

Feasibility and repeatability of PET with the hypoxia tracer [(18)F]HX4 in oesophageal and pancreatic cancer.

Klaassen R, Bennink RJ, van Tienhoven G, Bijlsma MF, Besselink MG, van Berge Henegouwen MI, Wilmink JW, Nederveen AJ, Windhorst AD, Hulshof MC, van Laarhoven HW.

Radiother Oncol. 2015 Jul;116(1):94-9. doi: 10.1016/j.radonc.2015.05.009. Epub 2015 Jun 3.

PMID:
26049919
9.

Quality of Life and Late Complications After Minimally Invasive Compared to Open Esophagectomy: Results of a Randomized Trial.

Maas KW, Cuesta MA, van Berge Henegouwen MI, Roig J, Bonavina L, Rosman C, Gisbertz SS, Biere SS, van der Peet DL.

World J Surg. 2015 Aug;39(8):1986-93. doi: 10.1007/s00268-015-3100-y.

10.

Endoscopic closure of acute perforations of the GI tract: a systematic review of the literature.

Verlaan T, Voermans RP, van Berge Henegouwen MI, Bemelman WA, Fockens P.

Gastrointest Endosc. 2015 May 21. pii: S0016-5107(15)02288-9. doi: 10.1016/j.gie.2015.03.1977. [Epub ahead of print] Review.

PMID:
26005015
11.

Endoscopy/EUS-guided fiducial marker placement in patients with esophageal cancer: a comparative analysis of 3 types of markers.

Machiels M, van Hooft J, Jin P, van Berge Henegouwen MI, van Laarhoven HM, Alderliesten T, Hulshof MC.

Gastrointest Endosc. 2015 May 7. pii: S0016-5107(15)02282-8. doi: 10.1016/j.gie.2015.03.1972. [Epub ahead of print]

PMID:
25957478
12.

Burden of spousal caregivers of stage II and III esophageal cancer survivors 3 years after treatment with curative intent.

Haj Mohammad N, Walter AW, van Oijen MG, Hulshof MC, Bergman JJ, Anderegg MC, van Berge Henegouwen MI, Henselmans I, Sprangers MA, van Laarhoven HW.

Support Care Cancer. 2015 Apr 18. [Epub ahead of print]

PMID:
25894882
13.

Establishment of patient-derived xenograft models and cell lines for malignancies of the upper gastrointestinal tract.

Damhofer H, Ebbing EA, Steins A, Welling L, Tol JA, Krishnadath KK, van Leusden T, van de Vijver MJ, Besselink MG, Busch OR, van Berge Henegouwen MI, van Delden O, Meijer SL, Dijk F, Medema JP, van Laarhoven HW, Bijlsma MF.

J Transl Med. 2015 Apr 11;13:115. doi: 10.1186/s12967-015-0469-1.

14.

Esophageal and Gastric Cancer Pearl: a nationwide clinical biobanking project in the Netherlands.

Haverkamp L, Parry K, van Berge Henegouwen MI, van Laarhoven HW, Bonenkamp JJ, Bisseling TM, Siersema PD, Sosef MN, Stoot JH, Beets GL, de Steur WO, Hartgrink HH, Verspaget HW, van der Peet DL, Plukker JT, van Etten B, Wijnhoven BP, van Lanschot JJ, van Hillegersberg R, Ruurda JP.

Dis Esophagus. 2015 Mar 30. doi: 10.1111/dote.12347. [Epub ahead of print]

PMID:
25824294
15.

Long-term effects of anti-reflux surgery on the physiology of the esophagogastric junction.

Kessing BF, Bredenoord AJ, Schijven MP, van der Peet DL, van Berge Henegouwen MI, Smout AJ.

Surg Endosc. 2015 Mar 19. [Epub ahead of print]

PMID:
25786903
16.

Simultaneous use of endoscopic resection and radiofrequency ablation is not safe in an esophageal porcine model.

Herrero LA, van Vilsteren FG, Visser M, Meijer SL, van Berge Henegouwen MI, Bergman JJ, Weusten BL.

Dis Esophagus. 2015 Jan;28(1):25-31.

PMID:
25756175
17.

A new concept of the anatomy of the thoracic oesophagus: the meso-oesophagus. Observational study during thoracoscopic esophagectomy.

Cuesta MA, Weijs TJ, Bleys RL, van Hillegersberg R, van Berge Henegouwen MI, Gisbertz SS, Ruurda JP, Straatman J, Osugi H, van der Peet DL.

Surg Endosc. 2015 Sep;29(9):2576-82. doi: 10.1007/s00464-014-3972-1. Epub 2014 Dec 6.

PMID:
25480608
18.

Lymph node retrieval during esophagectomy with and without neoadjuvant chemoradiotherapy: prognostic and therapeutic impact on survival.

Koen Talsma A, Shapiro J, Looman CW, van Hagen P, Steyerberg EW, van der Gaast A, van Berge Henegouwen MI, Wijnhoven BP, van Lanschot JJ; CROSS Study Group, Hulshof MC, van Laarhoven HW, Nieuwenhuijzen GA, Hospers GA, Bonenkamp JJ, Cuesta MA, Blaisse RJ, Busch OR, ten Kate FJ, Creemers GJ, Punt CJ, Plukker JT, Verheul HM, van Dekken H, van der Sangen MJ, Rozema T, Biermann K, Beukema JC, Piet AH, van Rij CM, Reinders JG, Tilanus HW.

Ann Surg. 2014 Nov;260(5):786-92; discussion 792-3. doi: 10.1097/SLA.0000000000000965.

PMID:
25379850
19.

Delphi survey to identify topics to be addressed at the initial follow-up consultation after oesophageal cancer surgery.

Jacobs M, Henselmans I, Macefield RC, Blencowe NS, Smets EM, de Haes JC, Sprangers MA, Blazeby JM, van Berge Henegouwen MI.

Br J Surg. 2014 Dec;101(13):1692-701. doi: 10.1002/bjs.9647. Epub 2014 Oct 15.

PMID:
25319127
20.

Preoperative chemoradiation therapy in combination with panitumumab for patients with resectable esophageal cancer: the PACT study.

Kordes S, van Berge Henegouwen MI, Hulshof MC, Bergman JJ, van der Vliet HJ, Kapiteijn E, van Laarhoven HW, Richel DJ, Klinkenbijl JH, Meijer SL, Wilmink JW.

Int J Radiat Oncol Biol Phys. 2014 Sep 1;90(1):190-6. doi: 10.1016/j.ijrobp.2014.05.022.

PMID:
25195993
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk